Keywords: Ipsen, Gingko biloba products, Delisting, Cognitive and Neurosensory disorders, France

French government delists certain Ipsen products

Article | 29 January 2012

Print This

French drugmaker Ipsen (Euronext: IPN) announced the French government’s decision to no longer reimburse its Gingko biloba products ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in